According to Grifols's latest financial reports and stock price the company's current number of shares outstanding is 678,910,694. At the end of 2022 the company had 678,910,694 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 0.67 B | -0.8% |
2021 | 0.68 B | 7.38% |
2020 | 0.63 B | -7.64% |
2019 | 0.69 B | 2.19% |
2018 | 0.67 B | -1.43% |
2017 | 0.68 B | 1.56% |
2016 | 0.67 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 254.57% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | -21.20% | ๐บ๐ธ USA |
Baxter BAX | 507,000,000 | -25.32% | ๐บ๐ธ USA |
Kimberly-Clark KMB | 338,100,000 | -50.20% | ๐บ๐ธ USA |